Solvac S.A. — M&A Activity 2022

Mar 15, 2022

Press release Inside/regulated information

Solvac fully supports Solvay's project to explore its separation into two independent publicly listed companies

Brussels, March 15, 2022 at 7:45 a.m.

Solvac S.A. ("Solvac"), the reference shareholder of Solvay S.A. ("Solvay"), announce its full support for Solvay's project to explore its separation into two independent publicly listed companies.

Jean-Marie Solvay, Chairman of the Solvac Board of Directors, commented, "Solvac Board of Directors is fully supportive of Solvay's project to explore its separation into two independent, publicly listed companies. We are delighted that Solvay's Board of Directors and the management team are taking this important step forward to accelerate long-term sustainable value creation for its shareholders.

Over the last years, Solvay has managed a successful transformation in a highly volatile global environment. The contemplated separation would firmly establish two industry leaders respectively in specialty and essential chemicals, each positioned to meet their key strategic, financial and sustainability goals.

Solvac is a strong believer in the role that essential chemistry plays in fulfilling humanity's needs and that specialties innovations play in resolving future unmet needs.

We are thus fully committed to supporting the long-term development of both companies as they would benefit from the required strategic and financial flexibility to focus on their specific business models, market and stakeholder priorities."

As such, Solvac commits to remain a reference shareholder in both companies through this next important phase of Solvay's evolution. As customary, Solvac will remain engaged in an open dialogue with Solvay during the transformation process.

Please note : Solvay's Press Release

Solvac is a public limited company under Belgian law founded in 1983 and listed on the Euronext Brussels stock exchange under the code ISIN BE0003545531 (SOLV). Its assets consist exclusively of a holding of more than 30% in the capital of Solvay SA. As a reference shareholder, Solvac supports the development of Solvay's industrial project. Its shares are exclusively nominative. They can be held freely by natural persons or, by legal or similar persons, with the approval of the Board of Directors and under the conditions set out in its approval policy. As of December 31, 2021, its market capitalization amounted to € 2.330 billion.